NuSil Technology LLC appoints Charles Kummeth to its board of directors. Kummeth is the President and Chief Executive Officer of Bio-Techne, a global life sciences company providing bioactive tools and resources for the research and clinical diagnostic communities.
“I am delighted that Chuck has agreed to join the NuSil Board,” said Ernest Waaser, Chief Executive Officer of NuSil Technology. “He brings over 30 years of global business and life sciences experience that will be invaluable to us as we continue to implement our strategy of accelerated growth and expansion in the life sciences and advanced engineering markets.”
Prior to Bio-Techne, Mr. Kummeth served as President of Mass Spectrometry and Chromatography at Thermo Fisher Scientific Inc. and was also President of the Laboratory Consumables Division. Prior to joining Thermo Fisher, Mr. Kummeth spent 24 years at 3M Corporation, most recently as Vice President of the company’s Medical Division.
“We are thrilled to have an executive of Chuck’s caliber joining the NuSil Board,” said Matt Holt, a member of the Board of Directors and Managing Director of New Mountain Capital, NuSil’s majority shareholder. “He has a tremendous track record of building value in high growth, differentiated life sciences businesses and we look forward to his insights and guidance as we continue to build on the outstanding growth momentum that has been established at NuSil.”
“It is an honor to join the Board of a high growth technology company that provides solutions to some of the most demanding applications in the world,” said Mr. Kummeth. “NuSil is a leader in silicone materials science with a unique set of capabilities and technologies, perfectly positioned for the many challenging medical applications of the future. I look forward to working with the Board and the management team to continue to grow and expand an already exceptional company.”